Six-month results of small vessel stenting (2.0-2.8 mm) with the Biodivysio SV stent.
We report the 6-month follow-up results of our initial retrospective experience with the Biodivysio small vessel (SV) stent (Biocompatibles, Galway, United Kingdom) designed for 2.0-2.8 mm vessel diameters. This stent is manufactured with a smaller stainless-steel tube (1.0 mm) and is coated with phosphorylcholine. Procedural success was 95.7% and the major adverse cardiac events at 6 months were 20%. We conclude that the Biodivysio SV stent is a safe device that does not induce excessive acute thrombosis or early restenosis.
Beaudry
Y
Y
Division of Cardiology, Montreal General Hospital, McGill University Health Center, Montreal, Quebec, Canada.
Sze
S
S
Fagih
B
B
Constance
C
C
Kwee
R
R
D000368:Aged; D004867:Equipment Design; D004869:Equipment Safety; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D017202:Myocardial Ischemia / Q000628:therapy*; D009204:Myocardial Revascularization / Q000295:instrumentation*; D012189:Retrospective Studies; D015607:Stents; D016896:Treatment Outcome